Mathes Company’s Celgene Corp CELG Stock Holding History

Mathes Company’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,040	Closed	-$213K	–	147
2017 Q4	$213K	Hold	2,040	–	–	0.1%	135
2017 Q3	$297K	Hold	2,040	–	–	0.14%	120
2017 Q2	$265K	Hold	2,040	–	–	0.13%	120
2017 Q1	$254K	Sell	2,040 -30	-1%	-$3.59K	0.14%	112
2016 Q4	$240K	Hold	2,070	–	–	0.13%	120
2016 Q3	$216K	Sell	2,070 -4,990	-71%	-$540K	0.12%	122
2016 Q2	$696K	Sell	7,060 -100	-1%	-$10.3K	0.41%	63
2016 Q1	$717K	Hold	7,160	–	–	0.43%	64
2015 Q4	$857K	Hold	7,160	–	–	0.49%	60
2015 Q3	$774K	Sell	7,160 -1,880	-21%	-$233K	0.51%	59
2015 Q2	$1.05M	Sell	9,040 -560	-6%	-$64K	0.56%	52
2015 Q1	$1.11M	Hold	9,600	–	–	0.57%	53
2014 Q4	$1.07M	Sell	9,600 -30	-0.3%	-$3.16K	0.56%	54
2014 Q3	$913K	Hold	9,630	–	–	0.46%	60
2014 Q2	$827K	Sell	9,630 -50	-0.5%	-$3.8K	0.41%	74
2014 Q1	$676K	Hold	9,680	–	–	0.36%	85
2013 Q4	$818K	Buy	9,680 +520	+6%	+$41.1K	0.44%	66
2013 Q3	$706K	Buy	9,160 +5,360	+141%	+$376K	0.67%	39
2013 Q2	$222K	Buy	+3,800	New	+$229K	0.24%	77

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mathes Company's CELG Position: Q1 2018 in Review

Mathes Company sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,040 shares — an estimated $213K sold.

Mathes Company first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $1.11M in Q1 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Mathes Company reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Mathes Company sold 2,040 Celgene Corp shares in Q1 2018, an estimated $213K.
Mathes Company first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
Mathes Company's Celgene Corp position peaked at $1.11M in Q1 2015.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Mathes Company's 13F filing for Q1 2018, filed 27 Apr 2018.